Globus Medical (NYSE:GMED) Stock Rating Upgraded by StockNews.com
Globus Medical (NYSE:GMED – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Friday. A number of other analysts have also commented on GMED. Canaccord Genuity Group boosted their target price on Globus Medical from $92.00 to $101.00 and gave […]
Globus Medical (NYSE:GMED – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Friday. A number of other analysts have also commented on GMED. Canaccord Genuity Group boosted their target price on Globus Medical from $92.00 to $101.00 and gave […]
